Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $5.2 million.

  • iSpecimen's Cash from Financing Activities rose 50810.59% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 44565.21%. This contributed to the annual value of $5.8 million for FY2024, which is 810846.82% up from last year.
  • Per iSpecimen's latest filing, its Cash from Financing Activities stood at $5.2 million for Q3 2025, which was up 50810.59% from $3.8 million recorded in Q4 2024.
  • Over the past 5 years, iSpecimen's Cash from Financing Activities peaked at $19.6 million during Q4 2021, and registered a low of -$3.5 million during Q4 2022.
  • In the last 5 years, iSpecimen's Cash from Financing Activities had a median value of $75277.0 in 2022 and averaged $2.3 million.
  • Examining YoY changes over the last 5 years, iSpecimen's Cash from Financing Activities showed a top increase of 4130450.36% in 2024 and a maximum decrease of 27547.24% in 2024.
  • Quarter analysis of 5 years shows iSpecimen's Cash from Financing Activities stood at $19.6 million in 2021, then plummeted by 117.88% to -$3.5 million in 2022, then skyrocketed by 100.09% to $3153.0 in 2023, then skyrocketed by 119541.45% to $3.8 million in 2024, then soared by 38.63% to $5.2 million in 2025.
  • Its Cash from Financing Activities was $5.2 million in Q3 2025, compared to $3.8 million in Q4 2024 and $859980.0 in Q3 2024.